Steven Schnelle discussed proposed drug pricing and transparency legislation, regulatory activity, and litigation at the Fall IDN Summit and Reverse Expo in Phoenix, Arizona, on September 9, 2019. Specific attention was paid to the Prescription Drug Pricing Reduction Act of 2019 (PDPRA), the Safe Importation Action Plan, and ongoing 340B reimbursement litigation.
For more information, please click here.
Chicago, IL / McDermott Event / October 10, 2019
Benefits Emerging Leaders Working GroupNew Orleans, LA / Speaking Engagements / September 10, 2019
International Society of Certified Employee Benefit Specialists: 38th Annual SymposiumPhoenix, AZ / Speaking Engagements / September 9, 2019
IDN Summit and Reverse Expo - Pharmacy Track: Pricing and TransparencySan Francisco, CA / Speaking Engagements / May 13, 2019
Digital Health Forum: Keeping Companies Dynamic, Agile and Maximizing ROI - Operational Risk Management iPhiladelphia, PA / Speaking Engagements / March 12-13, 2019
Pennsylvania Bar Institute Health Law Institute: Partnering for Telehealth and Artificial IntelligenceNashville, Tennessee / Speaking Engagements / February 6 - 9, 2019
ABA Section of Labor and Employment Law | 2019 Midwinter MeetingWe use cookies to improve the functionality and performance of this site. By continuing to use this site, you are providing us with your consent to our use of cookies. Please see our Privacy Policy for details.